Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 3 1

Status

Unknown 1Not yet recruiting 1Completed 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 36Neoplasms 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Neoplasm Metastasis 5Pancreatic Neoplasms 4Ovarian Neoplasms 3Lymphoma, Mantle-Cell 3Lung Neoplasms 3Leukemia, Myeloid, Acute 3Advanced Breast Cancer 3Sarcoma 2Recurrence 2Prostatic Neoplasms 2Multiple Myeloma 2Melanoma 2Lymphoma, Non-Hodgkin 2Inflammation 2Hereditary Sensory and Autonomic Neuropathies 2Head and Neck Neoplasms 2Colorectal Neoplasms 2Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Thrombosis 1Thromboembolism 1Thrombocytosis 1Squamous Cell Carcinoma of Head and Neck 1Primary Myelofibrosis 1Oligodendroglioma 1Neoplasms, Neuroepithelial 1Myeloproliferative Disorders 1

Interventions

Fulvestrant 4palbociclib 3Letrozole 3Paclitaxel 2sonidegib 1ribociclib 1irinotecan sucrosofate 1elacestrant 1XMT-1522 1Vorinostat 1Sirolimus 1Ritonavir 1Population Groups 1Itraconazole 1Immunotherapy, Adoptive 1Histone Deacetylase Inhibitors 1FCN-437c 1Docetaxel 1Decitabine 1Dasatinib 1Combined Modality Therapy 1Capecitabine 1CYH33 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Advanced Breast Cancer × palbociclib × Clear all
NCT02499146 2026-02-11

Palbociclib Pharmacokinetics Study In Postmenopausal Chinese Women With ER (+), HER2 (-) Advanced Breast Cancer

Pfizer

Phase 1 Completed
26 enrolled 40 charts
Breast

Advanced Breast Cancer

NCT06941142 2025-04-23

A Study of Sirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breast Cancer

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Phase 1 Not yet recruiting
382 enrolled
Breast

Advanced Breast Cancer

NCT04856371 2021-04-23

Study of CYH33 in Combination With Endocrine Therapy With or Without Palbociclib in Patients With HR+, HER2- Advanced Breast Cancer

Haihe Biopharma Co., Ltd.

Phase 1 Unknown
228 enrolled
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡